Cases 31 - 40 of 59
Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
as 1:2019cv01964
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Alkem Laboratories Ltd.
as 1:2019cv01493
Defendant:
Ascend Laboratories, LLC and Alkem Laboratories Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2019cv14394
Plaintiff:
NOVARTIS PHARMA AG, EISAI INC. and EISAI CO., LTD.
Defendant:
ALKEM LABORATORIES LTD. and ASCEND LABORATORIES, LLC
Cause Of Action: 15 U.S.C. § 1126
Eisai Co., Ltd. et al v. Alkem Laboratories Ltd. et al
as 1:2019cv01213
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. ALKEM LABORATORIES LTD.
as 3:2018cv17731
Defendant:
ALKEM LABORATORIES LTD.
Plaintiff:
DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. ALKEM LABORATORIES LTD.
as 3:2018cv16399
Defendant:
ALKEM LABORATORIES LTD.
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alkem Laboratories Ltd. et al
as 1:2018cv01738
Defendant:
Ascend Laboratories, LLC and Alkem Laboratories Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GMBH
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. ALKEM LABORATORIES LTD.
as 3:2018cv13905
Defendant:
ALKEM LABORATORIES LTD.
Plaintiff:
DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
